Use of modified Atkins diet in glucose transporter type 1 deficiency syndrome

Developmental Medicine and Child Neurology

Volumn 58, Issue 11, 2016, Pages 1193-1199

  Amalou, Sofiane ^a   Gras, Domitille ^a   Ilea, Adina ^a   Greneche, Marie Odile ^a   Francois, Laurent ^a   Bellavoine, Vanina ^a   Delanoe, Catherine ^a   Auvin, Stéphane ^a,b  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CLOBAZAM; ETHOSUXIMIDE; GLUCOSE TRANSPORTER 1; LAMOTRIGINE; LIPID; PROTEIN; SULTIAME; VALPROIC ACID;

ANTICONVULSANT THERAPY; ARTICLE; BENIGN CHILDHOOD EPILEPSY; CEREBELLAR ATAXIA; CHILD; CLINICAL ARTICLE; CONSTIPATION; CONTROLLED STUDY; DIET THERAPY; DIETARY COMPLIANCE; EPILEPTIC DISCHARGE; EYE MOVEMENT DISORDER; FEMALE; FEVER; FOLLOW UP; GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME; HUMAN; INFANT; INTELLECTUAL IMPAIRMENT; KETOACIDOSIS; KETOGENIC DIET; MALE; METABOLIC TRANSPORT DISORDER; MODIFIED ATKINS DIET; MOTOR DYSFUNCTION; MUSCLE HYPOTONIA; MYOCLONUS; OBSERVATIONAL STUDY; PHYSICAL CAPACITY; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; THERAPY EFFECT; VOMITING; WEAKNESS;

EID: 84989838385     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/dmcn.13167     Document Type: Article

References (23)

1. Devivo DC, Trifiletti RR, Jacobson RI, Ronen GM, Behmand RA, Harik SI. Defective glucose-transport across the blood–brain-barrier as a cause of persistent hypoglycorrhachia, seizures, and developmental delay. N Engl J Med 1991; 325: 703–09.
2. Vannucci SJ, Maher F, Simpson IA. Glucose transporter proteins in brain: delivery of glucose to neurons and glia. Glia 1997; 21: 2–21.
3. Leen WG, Klepper J, Verbeek MM, et al. Glucose transporter-1 deficiency syndrome: the expanding clinical and genetic spectrum of a treatable disorder. Brain 2010; 133: 655–70.
4. Hully M, Vuillaumier-Barrot S, Le Bizec C, et al. From splitting GLUT1 deficiency syndromes to overlapping phenotypes. Eur J Med Genet 2015; 58: 443–54.
5. Klepper J. Glut1 deficiency syndrome in clinical practice. Epilepsy Res 2012; 100: 272–77.
6. Pong AW, Geary BR, Engelstad KM, Natarajan A, Yang H, De Vivo DC. Glucose transporter type I deficiency syndrome: epilepsy phenotypes and outcomes. Epilepsia 2012; 53: 1503–10.
7. Klepper J. Glucose transporter deficiency syndrome (GLUT1DS) and the ketogenic diet. Epilepsia 2008; 49(Suppl. 8): 46–49.
8. Vijay N, Morris ME. Role of monocarboxylate transporters in drug delivery to the brain. Curr Pharm Des 2014; 20: 1487–98.
9. Auvin S. Should we routinely use modified Atkins diet instead of regular ketogenic diet to treat children with epilepsy? Seizure 2012; 21: 237–40.
10. Sharma S, Sankhyan N, Gulati S, Agarwala A. Use of the modified Atkins diet for treatment of refractory childhood epilepsy: a randomized controlled trial. Epilepsia 2013; 54: 481–86.
11. Leen WG, Mewasingh L, Verbeek MM, et al. Movement disorders in GLUT1 deficiency syndrome respond to the modified Atkins diet. Mov Disord 2013; 28: 1439–42.
12. Ito Y, Oguni H, Ito S, Oguni M, Osawa M. A modified Atkins diet is promising as a treatment for glucose transporter type 1 deficiency syndrome. Dev Med Child Neurol 2011; 53: 658–63.
13. Ito S, Oguni H, Ito Y, et al. Modified Atkins diet therapy for a case with glucose transporter type 1 deficiency syndrome. Brain Dev 2008; 30: 226–28.
14. Haberlandt E, Karall D, Jud V, et al. Glucose transporter type 1 deficiency syndrome effectively treated with modified Atkins diet. Neuropediatrics 2014; 45: 117–19.
15. Ramm-Pettersen A, Stabell KE, Nakken KO, Selmer KK. Does ketogenic diet improve cognitive function in patients with GLUT1-DS? A 6-to 17-month follow-up study. Epilepsy Behav 2014; 39: 111–15.
16. Slaughter L, Vartzelis G, Arthur T. New GLUT-1 mutation in a child with treatment-resistant epilepsy. Epilepsy Res 2009; 84: 254–56.
17. Ohshiro-Sasaki A, Shimbo H, Takano K, Wada T, Osaka H. A three-year-old boy with glucose transporter type 1 deficiency syndrome presenting with episodic ataxia. Pediatr Neurol 2014; 50: 99–100.
18. Porta N, Vallee L, Boutry E, et al. Comparison of seizure reduction and serum fatty acid levels after receiving the ketogenic and modified Atkins diet. Seizure 2009; 18: 359–64.
19. Leary LD, Wang T, Nordli DR, Engelstad K, De Vivo DC. Seizure characterization and electroencephalographic features in glut-1 deficiency syndrome. Epilepsia 2003; 44: 701–07.
20. De Giorgis V, Teutonico F, Cereda C, et al. Sporadic and familial GLUT1DS Italian patients: a wide clinical variability. Seizure 2015; 24: 28–32.
21. De Giorgis V, Veggiotti P. GLUT1 deficiency syndrome 2013: current state of the art. Seizure 2013; 22: 803–11.
22. Kitamura Y, Okumura A, Hayashi M, et al. Oxidative stress markers and phosphorus magnetic resonance spectroscopy in a patient with GLUT1 deficiency treated with modified Atkins diet. Brain Dev 2012; 34: 372–75.
23. Woo SB, Lee K-H, Kang H-C, Yang H, De Vivo DC, Kim SK. First report of glucose transporter 1 deficiency syndrome in Korea with a novel splice site mutation. Gene 2012; 506: 380–82.